Pentasa and condition aggravated Patient Reports February 12, 2012

Pentasa Side Effects Report #5398343-0
Pentasa side effect was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 61 years of age, weighting 134.9 lb, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: condition aggravated, crohn's disease , paraesthesia. Pentasa dosage: 250 MG, 4X/DAY;QID, ORAL. During the same period patient was treated with FLAGYL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4727739-2
Pentasa side effect was reported by a Health Professional from JAPAN on July 13, 2005. Male patient, 34 years of age, was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: condition aggravated, crohn's disease , infection , pneumonia , urinary tract infection , white blood cell count increased. Pentasa dosage: unknown. During the same period patient was treated with REMICADE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5972024-4
Pentasa side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2008. Female patient was diagnosed with crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, crohn's disease , off label use, pain . Pentasa dosage: unknown. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5398780-4
Pentasa side effect was reported by a Consumer or non-health professional from DENMARK on July 12, 2007. Male patient, 63 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, disease recurrence, interstitial lung disease, pneumonia cytomegaloviral, pyrexia, rash , white blood cell count increased. Pentasa dosage: 1000 MG, 3X/DAY:TID, ORAL; 250 MG, 1X/DAY; QD, ORAL. During the same period patient was treated with PREDNISOLONE. Patient recovered.


Pentasa Side Effects Report #5309019-X
Pentasa side effect was reported by a Physician from JAPAN on Apr 06, 2007. Male patient, 56 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: condition aggravated, eosinophilic pneumonia, malaise, respiratory failure. Pentasa dosage: 750 MG 3XS DAILY, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5390021-7
Pentasa side effect was reported by a Pharmacist from JAPAN on June 29, 2007. Male patient, 52 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: arthralgia, back pain , colitis ulcerative, condition aggravated, pain in jaw, pyrexia. Pentasa dosage: 500 MG, 3X/ DAY:TID, ORAL, 750 MG, 1X/DAY; QD, ORAL. During the same period patient was treated with TIQUIZIUM BROMIDE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5918342-7
Pentasa side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2008. Female patient, 45 years of age, weighting 123.0 lb, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: colitis ulcerative, condition aggravated, gallbladder operation. Pentasa dosage: 2000 MG,4000 MG, 1X/DAY;QD, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4568443-3
Pentasa side effect was reported by a Consumer or non-health professional from on Jan 18, 2005. Male patient, 43 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: colitis ulcerative, condition aggravated, interstitial lung disease. Pentasa dosage: unknown. During the same period patient was treated with PREDNISOLONE PHOSPHATE, GRANULOCYTE APHAERESIS. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4600439-5
Pentasa side effect was reported by a Consumer or non-health professional from on Feb 15, 2005. Female patient, 43 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: condition aggravated, cross sensitivity reaction, hypersensitivity, skin test positive. Pentasa dosage: unknown. Patient was hospitalized. Patient recovered.


Pentasa Side Effects Report #4865840-3
Pentasa side effect was reported by a Consumer or non-health professional from FRANCE on Dec 06, 2005. Female patient, 38 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: bronchospasm, chest discomfort, condition aggravated, diarrhoea, oedema peripheral, pyrexia, transaminases increased, urticaria, urticaria localised. Pentasa dosage: 500 MG DAILY, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5292053-6
Pentasa side effect was reported by a Health Professional from POLAND on Mar 19, 2007. Male patient, 35 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: anaemia, asthenia, colitis ulcerative, condition aggravated, cough, haematochezia, hyperglycaemia, lung disorder. Pentasa dosage: unknown. During the same period patient was treated with SULFASALAZINE. Patient recovered.

Pentasa Side Effects Report #5314608-2
Pentasa side effect was reported by a Physician from JAPAN on Apr 13, 2007. Female patient, 34 years of age, was diagnosed with colitis ulcerative, sepsis , pyrexia and was treated with Pentasa. After drug was administered, patient experienced the following side effects: blood beta-d-glucan increased, cd4 lymphocytes decreased, cd8 lymphocytes decreased, colitis ulcerative, condition aggravated, decreased immune responsiveness, dehydration, gastrointestinal infection, renal impairment. Pentasa dosage: unknown. During the same period patient was treated with MEROPEN, ROPION. Patient recovered.

Pentasa Side Effects Report #4719241-9
Pentasa side effect was reported by a Health Professional from DENMARK on July 05, 2005. Male patient, 32 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: cardiomegaly, colitis ulcerative, condition aggravated, pericarditis, pleural effusion, pleurisy. Pentasa dosage: 750; 500 MG, 3X/DAY:TID, ORAL. During the same period patient was treated with POLYCARBOPHIL, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4939962-2
Pentasa side effect was reported by a Health Professional from JAPAN on Feb 22, 2006. Female patient, 32 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: arthralgia, colitis ulcerative, condition aggravated, enterocolitis. Pentasa dosage: 500 MG, 3X/DAY: TID, ORAL. During the same period patient was treated with THEOPHYLLINE, EPINASTINE HYDROCHLORIDE, PROCATEROL, PRANLUKAST, SALMETEROL XINAFOATE, BECLOMETHASONE DIPROPIONATE, RABEPRAZOLE. Patient was hospitalized. Patient recovered.


Pentasa Side Effects Report #5935192-6
Pentasa side effect was reported by a Physician from UNITED STATES on Oct 16, 2008. Female patient, 29 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: colitis ulcerative, condition aggravated, exercise electrocardiogram abnormal, hypotension, left ventricular hypertrophy, nodal rhythm, sinus arrest, sinus bradycardia, ventricular dysfunction. Pentasa dosage: unknown. During the same period patient was treated with LOPERAMIDE. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4614150-8
Pentasa side effect was reported by a Health Professional from on Feb 24, 2005. Male patient, 26 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, chronic hepatitis, colitis ulcerative, condition aggravated, hepatic fibrosis, lymphocyte stimulation test positive, splenomegaly. Pentasa dosage: unknown. During the same period patient was treated with SCOPOLAMINE. Patient recovered.

Pentasa Side Effects Report #5065285-X
Pentasa side effect was reported by a Consumer or non-health professional from DENMARK on July 08, 2005. Male patient, 20 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: condition aggravated, pancreatitis acute. Pentasa dosage: 2250 MG DAILY, ORAL. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #4704546-8
Pentasa side effect was reported by a Health Professional from on June 15, 2005. Female patient, 19 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: antineutrophil cytoplasmic antibody positive, antinuclear antibody positive, asthma , cd4/cd8 ratio decreased, condition aggravated, eosinophilia, interstitial lung disease, leukocytosis, pulmonary fibrosis . Pentasa dosage: unknown. During the same period patient was treated with SERETIDE DISKUS. Patient was hospitalized. Patient recovered.

Pentasa Side Effects Report #5206804-X
Pentasa side effect was reported by a Health Professional from SWEDEN on Dec 25, 2006. Male patient, 17 years of age, was diagnosed with colitis ulcerative and was treated with Pentasa. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, colitis ulcerative, condition aggravated, disseminated intravascular coagulation, haematuria, haemorrhage subcutaneous, scar . Pentasa dosage: 2250 MG DAILY, ORAL; 1500 MG DAILY, ORAL; 2250 MG DAILY, ORAL. During the same period patient was treated with MESALAMINE, CEFDINIR, CEFAZOLIN, FAMOTIDINE, PREDNISONE ACETATE, AMPICILLIN W. Patient recovered.


Pentasa Side Effects Report #5568121-8
Pentasa side effect was reported by a Physician from UNITED STATES on Dec 11, 2007. Female patient, 31 years of age, was diagnosed with colitis, crohn's disease  and was treated with Pentasa. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, arthralgia, atelectasis, chest pain , condition aggravated, crohn's disease , diarrhoea, dyspnoea. Pentasa dosage: unknown. During the same period patient was treated with COLESTID, ASACOL. Patient was hospitalized. Patient recovered.